// App-Quantinova.ai

: Trial Readiness amongst EPAD Longitudinal Cohort Study Participants: Insights from the SPEAR study

Researchers

Presenter

  • Natassia F. Brenman

Principal Investigators

  • Richard Milne

  • Carol Brayne

Medical Centers

  • Wellcome Genome Campus

  • Goldsmiths, University of London

  • University of Cambridge,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved